Literature DB >> 8390857

Comparative sequence specificities of human 72- and 92-kDa gelatinases (type IV collagenases) and PUMP (matrilysin).

S Netzel-Arnett1, Q X Sang, W G Moore, M Navre, H Birkedal-Hansen, H E Van Wart.   

Abstract

The sequence specificities of human 72-kDa fibroblast gelatinase (type IV collagenase), human 92-kDa neutrophil gelatinase (type IV collagenase), and putative metalloproteinase (PUMP or matrilysin) have been examined by measuring the rate of hydrolysis of over 50 synthetic oligopeptides covering the P4 through P4' subsites of the substrate. The peptides investigated in this paper were those employed in our previous study which systematically examined the sequence specificity of human fibroblast and neutrophil collagenases [Netzel-Arnett et al. (1991) J. Biol. Chem. 266, 6747]. The initial rate of hydrolysis of the P1-P1' bond of each peptide has been measured under first-order conditions ([S0] << KM), and kcat/KM values have been calculated from the initial rates. The specificities of these five metalloproteinases are similar, but distinct, with the largest differences occurring at subsites P1, P1', and P3'. The specificities of the two gelatinases are the most similar to each other. They tolerate only small amino acids such as Gly and Ala in subsite P1. In contrast, larger residues such as Met, Pro, Gln, and Glu are also accommodated well by PUMP. All five enzymes prefer hydrophobic, aliphatic residues in subsite P1'. PUMP exhibits a stronger preference for Leu in this subsite than is shown by the other enzymes. The P3' subsite specificities of the gelatinases and collagenases are very similar but different from those of PUMP which particularly prefers Met in this position. The specificity data from this study allow the design of optimized substrates and selective inhibitors for these metalloproteinases.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8390857     DOI: 10.1021/bi00076a016

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  22 in total

1.  Using fluorogenic peptide substrates to assay matrix metalloproteinases.

Authors:  G B Fields
Journal:  Methods Mol Biol       Date:  2001

2.  pH- and temperature-dependence of functional modulation in metalloproteinases. A comparison between neutrophil collagenase and gelatinases A and B.

Authors:  G F Fasciglione; S Marini; S D'Alessio; V Politi; M Coletta
Journal:  Biophys J       Date:  2000-10       Impact factor: 4.033

Review 3.  Matrix metalloproteinase inhibitors: a critical appraisal of design principles and proposed therapeutic utility.

Authors:  György Dormán; Sándor Cseh; István Hajdú; László Barna; Dénes Kónya; Krisztina Kupai; László Kovács; Péter Ferdinandy
Journal:  Drugs       Date:  2010-05-28       Impact factor: 9.546

4.  Structure of malonic acid-based inhibitors bound to human neutrophil collagenase. A new binding mode explains apparently anomalous data.

Authors:  H Brandstetter; R A Engh; E G Von Roedern; L Moroder; R Huber; W Bode; F Grams
Journal:  Protein Sci       Date:  1998-06       Impact factor: 6.725

5.  Computational sequence analysis of matrix metalloproteinases.

Authors:  Q A Sang; D A Douglas
Journal:  J Protein Chem       Date:  1996-02

6.  Matrix metalloproteinase 9 expression is induced by Epstein-Barr virus latent membrane protein 1 C-terminal activation regions 1 and 2.

Authors:  H Takeshita; T Yoshizaki; W E Miller; H Sato; M Furukawa; J S Pagano; N Raab-Traub
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

7.  Matrix metalloproteinase-9 reduces islet amyloid formation by degrading islet amyloid polypeptide.

Authors:  Kathryn Aston-Mourney; Sakeneh Zraika; Jayalakshmi Udayasankar; Shoba L Subramanian; Pattie S Green; Steven E Kahn; Rebecca L Hull
Journal:  J Biol Chem       Date:  2012-12-10       Impact factor: 5.157

8.  Development of a novel fluorogenic proteolytic beacon for in vivo detection and imaging of tumour-associated matrix metalloproteinase-7 activity.

Authors:  J Oliver McIntyre; Barbara Fingleton; K Sam Wells; David W Piston; Conor C Lynch; Shiva Gautam; Lynn M Matrisian
Journal:  Biochem J       Date:  2004-02-01       Impact factor: 3.857

9.  Glial hyaluronate-binding protein: a product of metalloproteinase digestion of versican?

Authors:  G Perides; R A Asher; M W Lark; W S Lane; R A Robinson; A Bignami
Journal:  Biochem J       Date:  1995-12-01       Impact factor: 3.857

10.  Phosphinic peptide analogues as potent inhibitors of Corynebacterium rathayii bacterial collagenase.

Authors:  A Yiotakis; A Lecoq; A Nicolaou; J Labadie; V Dive
Journal:  Biochem J       Date:  1994-10-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.